FOUNTAIN HILLS, Ariz.,
Oct. 13 /PRNewswire/ -- Sunridge
International (OTC Bulletin Board: SNDZ), announced today it
received an order for additional inventory from New Amsterdam
Marketing Corporation, its exclusive distributor in India and Bangladesh. New Amsterdam personnel are
currently on a two-week marketing road show in multiple cities
throughout India and Bangladesh. New Amsterdam's personnel is
accompanied by Leo D. Bores M.D., a
medical consultant for Sunridge. Together, they are training
doctors, treating patients and providing informational seminars to
the public.
Midway through the road show, sales have already surpassed
inventory, making it necessary to reorder additional equipment and
supplies to meet the demand.
Glaucoma is the second leading cause of blindness, affecting
over 70 million people worldwide. PNT has been proven (through
studies completed over the last 10 yrs) to be a safe, effective,
non-invasive and a cost effective alternative for treatment for
glaucoma and ocular hypertension. The 2-minute treatment has been
developed, patented, and distributed by Sunridge International,
wholly owned subsidiary, Ophthalmic International
(www.oi-pnt.com).
For full details of PNT and its application, we invite you to
visit Sunridge International's website at www.sunridgeint.com.
CONTACT:
|
|
Jeff Smith,
Sunridge International
|
|
T:
+1-480-837-6165
|
|
e-mail:
info@sunridgeint.com
|
|
|
|
MEDIA:
|
|
Victor Webb,
Marston Webb International
|
|
T: (212)
684-6601
|
|
e-mail:
marwebint@cs.com
|
|
|
SOURCE Sunridge International
Copyright . 13 PR Newswire